Hillsdale Investment Management Inc. Grows Stake in Tenet Healthcare Corporation $THC

Hillsdale Investment Management Inc. increased its position in Tenet Healthcare Corporation (NYSE:THC) by 20.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,490 shares of the company’s stock after purchasing an additional 4,690 shares during the period. Hillsdale Investment Management Inc.’s holdings in Tenet Healthcare were worth $5,463,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Boston Partners boosted its stake in Tenet Healthcare by 38.8% in the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after purchasing an additional 880,413 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after purchasing an additional 157,109 shares in the last quarter. AQR Capital Management LLC boosted its stake in Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after purchasing an additional 720,160 shares in the last quarter. Eminence Capital LP bought a new position in Tenet Healthcare in the 3rd quarter worth about $225,263,000. Finally, Bank of America Corp DE boosted its stake in Tenet Healthcare by 9.6% in the 3rd quarter. Bank of America Corp DE now owns 1,078,585 shares of the company’s stock worth $218,996,000 after purchasing an additional 94,903 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Price Performance

NYSE THC opened at $174.83 on Friday. Tenet Healthcare Corporation has a 52 week low of $146.60 and a 52 week high of $247.21. The firm has a market capitalization of $15.06 billion, a P/E ratio of 9.09, a PEG ratio of 1.15 and a beta of 1.30. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The company has a 50-day moving average price of $189.94 and a 200-day moving average price of $201.87.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the prior year, the firm earned $4.36 EPS. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities research analysts anticipate that Tenet Healthcare Corporation will post 17.67 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. Jefferies Financial Group upped their price target on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Truist Financial boosted their target price on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Wells Fargo & Company decreased their target price on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Robert W. Baird decreased their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research report on Tuesday, May 5th. Finally, KeyCorp decreased their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Nineteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $244.16.

Insider Activity

In other news, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This represents a 25.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Thomas W. Arnst sold 8,000 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $238.85, for a total value of $1,910,800.00. Following the transaction, the executive vice president owned 12 shares of the company’s stock, valued at approximately $2,866.20. This trade represents a 99.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 55,155 shares of company stock worth $12,459,105. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.